Gut hormone GIP may hold key to stronger bones
NCT ID NCT06790225
First seen Jan 04, 2026
Summary
This study looks at how a natural gut hormone called GIP affects bone remodeling. Researchers will give GIP to 12 healthy adults in two ways—intermittent (8 hours daily) and continuous (24 hours daily)—to see which better reduces bone breakdown. Blood samples and bone marrow tests will measure changes in bone cell activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University hospital of Southern Denmark
RECRUITINGEsbjerg, 6700, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Glucose-dependent Insulinotropic Polypeptide (GIP)
What this could lead to
If successful, this could clarify how GIP affects bone health, potentially guiding future treatments for bone diseases in people with diabetes or obesity.
What could go wrong
This is a very small, early-stage study in healthy volunteers, not patients. Results may not apply to people with bone disease or diabetes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.